Banani Poddar, Jyoti Narayan Sahoo, Mohan Gurjar, Ratender Singh, Afzal Azim
|
|
- Gervais Harrell
- 6 years ago
- Views:
Transcription
1 Case Report Deep-vein thrombosis and septic pulmonary emboli in methicillin-sensitive Staphylococcus aureus infection Banani Poddar, Jyoti Narayan Sahoo, Mohan Gurjar, Ratender Singh, Afzal Azim Department of Critical Care Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Deep-vein thrombosis (DVT) in children is most often secondary to a predisposing cause. DVT and septic pulmonary emboli in staphylococcal sepsis has been described most often with methicillin-resistant Staphylococcus aureus. The clinical features of four previously healthy children with community-acquired, methicillin-sensitive Staphylococcus aureus sepsis associated with DVT are described. Keywords: Pneumonia, Staphylococcal, Intensive care unit, Paediatric, Venous thrombo-embolism, Embolism, Pulmonary Introduction Staphylococcus aureus, a gram-positive, coagulasepositive bacterium, is an important human pathogen. Invasive infection with community-acquired, methicillin-resistant Staphylococcus aureus (MRSA) is reported increasingly from industrialised countries, often associated with genes encoding for Panton- Valentine leucocidin (PVL). 1 Severe communityacquired staphylococcal infections, many requiring intensive care, have been reported in India. 2 4 Contrary to the situation in industrialised countries, almost all these infections are methicillin-sensitive S. aureus (MSSA). The manifestations are myriad and include pleuro-pulmonary disease, pyopericardium, musculoskeletal involvement, meningitis and, occasionally, endocarditis. However, deep-vein thrombosis (DVT) has been reported infrequently 4 6 and association with septic pulmonary emboli in MSSA infections is rare. 5 8 Four successfully managed cases of invasive staphylococcal infection, all MSSA, presenting with DVT are presented. Subjects and Methods The medical charts and radiological and laboratory findings in four consecutive children with S. aureus infection and DVT (including the details of one previously published 7 ) admitted to the intensive care unit (ICU) of Sanjay Gandhi Postgraduate Institute Correspondence to: B Poddar, Department of Critical Care Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Fax: z ; bananip@sgpgi.ac.in of Medical Sciences, Lucknow were retrospectively reviewed. All were infected by methicillin-sensitive S. aureus and had DVT, and three of them had septic pulmonary embolism. Details of the presenting histories and sites of involvement are shown in Table 1. All were males aged between 8 and 14 years and presented with a history of limb pain and swelling, fever and respiratory distress for 5 8 days (median 6.5). Their admission laboratory profiles are shown in Table 2. Qualitative assay of D-dimer was positive in all, with normal to raised fibrinogen level (range mmol/l). There was no family history of thrombotic tendency and work-up for hypercoagulability was negative in all patients. All four patients had clinical features suggestive of bronchopneumonia with abnormal chest radiographs (Table 3). CT of the chest undertaken in three children showed multiple pleural-based, ill defined densities of varying sizes with central cavitation and a feeding vessel, consistent with septic pulmonary emboli (Figure 1), and one had hydropneumothorax. Doppler flow study identified DVT of lower limb veins in three and an upper limb vein in one. Echocardiography was normal in all patients. MRI of affected limbs was undertaken and showed effusion of the hip joint in one patient with osteomyelitis of the right femur neck, and shoulder joint effusion in another. Myositis was detected around the corresponding joints. Supportive therapies given in the ICU are detailed in Table 3. Two children required mechanical ventilation ß W. S. Maney & Son Ltd 2013 DOI / Y Paediatrics and International Child Health 2013 VOL. 33 NO. 1 49
2 Table 1 Presenting complaints and sites of involvement Case 1* Case 2 Case 3 Case 4 Age, yrs Gender M M M M History of boils Yes No No No History of trauma No No No Yes Onset of illness to hospital admission, days Symptoms, days Left lower limb pain and swelling (8) Right lower limb pain and swelling (5) Left upper limb pain and swelling (8) Right lower limb pain and swelling (6) Fever (7) Fever (3) Fever (7) Fever (1) Resp. distress (1) Resp. distress (2) Resp. distress (2) Resp. distress (1) Primary site of infection Left thigh Right thigh Left upper limb Right foot ulcer Bone or joint involvement No Right hip, left elbow, Osteomyelitis right femur * Details published previously 7 Myositis around left shoulder joint No and vasopressor infusions. All patients were treated with antibiotics for 4 6 weeks. The patients were anticoagulated with heparin and this was changed to vitamin K antagonists once they stabilised. The international normalised ratio (INR) was maintained at between 2 and 3. This was continued for 3 months and then discontinued as no prothrombotic state was found in any of the patients. The median ICU stay was 20 days (range 6 30); the two boys on vasopressors and mechanical ventilation had a prolonged stay in the ICU. Three children are on follow-up and are well. One boy with osteomyelitis of the right femur neck was referred to another hospital for orthopaedic intervention and is lost to follow-up. Discussion S. aureus is a well recognised pathogen and disseminated disease in previously healthy children is well described. 2,3 However, in a review of 50 children with disseminated staphylococcal disease requiring ICU care in Chandigarh, India, none was reported to have deep-vein thrombosis. 2 In many countries since the late 1990s, the epidemiology of community-acquired S. aureus has changed from MSSA to virulent MRSA strains. 1,9 Strains of S. aureus with genes encoding PVL were implicated in this serious invasive disease. 1,5,9 However, recent literature has questioned the role of PVL in the virulence of staphylococcal disease; 1 other factors which promote necrosis such as a-toxin and novel cytolytic peptides (e.g. phenol-soluble modulinlike peptides or PSMs) might play a more important role. Furthermore, the expression of these virulence factors is influenced by differential gene expression, thus affecting virulence of the organism. Venous thrombo-embolism is rare in childhood and is typically associated with the presence of central venous catheters, trauma, sepsis, malignancies and preexisting coagulation disorders. 5 They occur in 0.07/ 10,000 children, with neonates and adolescents being at highest risk. 10 The incidence of pulmonary embolism in children is low; however, mortality rates may be as high as 30%. Various genetic prothrombotic defects affecting the physiological anticoagulant system have been identified as risk factors for thrombotic events. In 2000, three Israeli children were reported with a triad of DVT, septic pulmonary embolism and acute osteomyelitis associated with staphylococcal disease, and the authors proposed that the venous thrombus acts as a focus of infection and leads to disseminated disease. 8 Subsequent studies from Houston, Texas 5 and Taiwan 6 also found the same association. Septic DVT occurs following the release of various exotoxins, a-toxin and coagulase being the most important. a-toxin acts on cell membranes and produces aggregation of platelets and vascular spasm, while Table 2 Laboratory investigations on admission Case 1 Case 2 Case 3 Case 4 Total leukocyte count /L Platelet count /L Haemoglobin, g/dl PT patient/control, sec 17.1/ / / /11.6 APTT patient/control, sec 42.1/ / / /27.2 APLA Absent Absent Absent Absent Protein C, protein S assay Normal Not done Borderline low Normal Factor V Leiden mutation Absent Absent Absent Absent Homocysteine level Normal Not done Normal Not done Cultures showing growth of S. aureus (methicillin-sensitive) Blood Blood Blood Wound swab Pus from hip joint Tracheal aspirate Pleural aspirate PT, prothrombin time; APTT, activated partial thromboplastin time; APLA, anti-phospholipid antibodies. 50 Paediatrics and International Child Health 2013 VOL. 33 NO. 1
3 Table 3 Radiology and interventions Case 1 Case 2 Case 3 Case 4 Chest radiograph Nodular opacity Nodular opacity Left pleural effusion Consolidation, right lung, pleural effusion Right superficial and deep femoral vein thrombosis Left axillary and brachial vein thrombosis Distal part of right common iliac vein, upper 3rd of superficial femoral vein thrombosis Doppler Left common iliac vein, superficial & deep femoral vein thrombosis Minimal effusion left shoulder joint Oedema & inflammation of muscles of Inflammation, oedema & small fluid adductor compartment of right thigh Osteomyelitis right femur neck, effusion right hip joint MRI soft tissue and bone Oedema & inflammation of left thigh muscles. collections in the surrounding muscles Echo Normal Normal Normal Normal CT chest SPE SPE SPE, hydropneumothorax Not done Antibiotic therapy Vancomycin initially, later cloxacillin z Cloxacillin z amikacin Cloxacillin z amikacin Cloxacillin z amikacin (amikacin 61 wk) amikacin Oxygen therapy Yes Yes Yes Yes Mechanical ventilation, days 3 No 10 No Vasopressor, days 2 No 6 No Short-term anticoagulant Unfractionated heparin Low-molecular-weight heparin Unfractionated heparin Low-molecular-weight heparin Not done Thrombosis resolved in 13 days Thrombosis resolved in 5 days Follow-up doppler Thrombosis resolved several months later Long-term DVT prophylaxis Vit. K antagonist Not known Vit K antagonist Vit. K antagonist ICU stay, days Discharged Discharged Outcome Discharged Referred for orthopaedic intervention (lost to follow-up) MRI, magnetic resonance imaging; SPE, septic pulmonary emboli; CT, computed tomography; DVT, deep-vein thrombosis Figure 1 (arrows) CT chest: multiple septic pulmonary emboli coagulase interacts with fibrinogen and causes plasma to clot. These predispose to the development of DVT adjacent to deep-seated foci of infection. 5,8 In a recent study of DVT associated with staphylococcal disease, transient prothrombotic abnormalities were present which normalised on follow-up. 5 We found no underlying prothrombotic state in any of our patients. In a study of ten children with septic pulmonary emboli (SPE), nine were owing to S. aureus, seven of which were community-acquired. 6 All but one of the isolates were MRSA. In another study in Houston, Texas, of nine children with DVT related to invasive staphylococcal disease, seven isolates were MRSA and septic pulmonary emboli were found in four. 5 In our study, the invasive staphylococcal disease was MSSA in all four patients. Considering the magnitude of invasive staphylococcal disease in developing countries, it is likely that many cases of venous thrombosis and pulmonary emboli are being missed, contributing to the high mortality of this disease. This might be partly because of a lack of appropriate haematological investigations and chest imaging. Furthermore, we speculate that the virulence of community-acquired staphylococcal disease, albeit methicillin-sensitive, has increased to a level approaching that seen in industrialised countries. In the absence of molecular analysis, the presence of genes encoding for PVL or PSMs remains speculative. Hence, molecular analysis of community-acquired S. aureus strains is warranted in India and other developing countries. The diagnosis of invasive S. aureus infection with pulmonary lesions should prompt the physician to search for DVT as a source for septic emboli. Doppler ultrasonography is a good tool for detecting DVT in the thigh and popliteal areas with a sensitivity of % and a specificity of %. 11 Paediatrics and International Child Health 2013 VOL. 33 NO. 1 51
4 Aggressive treatment with appropriate antibiotics, anticoagulation, surgical drainage, and assisted ventilation, when indicated, are the cornerstones for treatment of this life-threatening triad of staphylococcal infection, DVT and septic emboli. 7,8 Antibiotics should be continued for 4 6 weeks as the DVT acts as a deep-seated source of infection. Screening for prothrombotic conditions is necessary to decide the duration of anticoagulation. Therapeutic anticoagulation with heparin (unfractionated or low molecular weight) is recommended, followed by oral vitamin K antagonists (with INR monitoring); these may be discontinued after 3 months if no prothrombotic condition is found. 12 References 1 DeLeo FR, Diep B A, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am. 2009;23: Baranwal AK, Singhi SC, Jayashree M. A 5-year PICU experience of disseminated staphylococcal disease, part 2: management, critical care needs and outcome. J Trop Pediatr. 2007;53: Kabra SK, Jain Y, Kataria A, John S, Chatterjee A, Seth V. Disseminated staphylococcal disease. Indian Pediatr. 1996;33: Prasad R, Mishra OP, Pant P. Deep vein thrombosis with Staphylococcus aureus infection. Indian Pediatr. 2007;44: Gonzales BE, Teruya J, Mahoney DH, Hulten KG, Edwards R, Lamberth LB, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117: Wong KS, Lin TY, Huang YC, Hsia SH, Yang PH, Chu SM. Clinical and radiographic spectrum of septic pulmonary embolism. Arch Dis Child. 2002;87: Joshi MC, Baronia AK, Singh RK, Poddar B. Staphylococcal sepsis presenting with septic pulmonary embolism. Indian J Pediatr. 2010;77: Gorenstein A, Gross E, Houri S, Gewirts G, Katz S. The pivotal role of deep vein thromphlebitis in the development of acute disseminated staphylococcal disease in children. Pediatrics. 2000;106:E87. 9 Miller LG, Kaplan SL. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am. 2009;23: Nowak-Gottl U, Kosch A. Factor VIII, D-dimer, and thromboembolism in children. N Engl J Med. 2004;351: Elliott CG, Lovelace TD, Brown LM, Adams D. Diagnosis: imaging techniques. Clin Chest Med. 2010;31: Monagle P, Chalmers E, Chan A, de Veber G, Kirkham F, Massicotte P, Michelson AD. Antithrombotic therapy in neonates and children. Chest. 2008;133: S. 52 Paediatrics and International Child Health 2013 VOL. 33 NO. 1
5 Copyright of Paediatrics & International Child Health is the property of Maney Publishing and its content may not be copied or ed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or articles for individual use.
Vascular Surgery Department, Santa Maria Hospital, Lisbon Medical Faculty, Lisbon, Portugal
International Pediatrics Volume 2010, Article ID 651023, 4 pages doi:10.1155/2010/651023 Case Report Septic Pulmonary Embolism Case Report: Optimal Outcome after Insertion of an Inferior Vena Cava Filter
More informationVTE in Children: Practical Issues
VTE in Children: Practical Issues Wasil Jastaniah MBBS,FAAP,FRCPC Consultant Pediatric Hem/Onc/BMT May 2012 Top 10 Reasons Why Pediatric VTE is Different 1. Social, ethical, and legal implications. 2.
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationDVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center
DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the
More informationCase Report Internal Jugular Vein Thrombosis in Isolated Tuberculous Cervical Lymphadenopathy
Volume 2016, Article ID 5184196, 4 pages http://dx.doi.org/10.1155/2016/5184196 Case Report Internal Jugular Vein Thrombosis in Isolated Tuberculous Cervical Lymphadenopathy Sanjay Khaladkar, Avadhesh
More informationPE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP
PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationEarly Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic
Early Klebsiella pneumoniae Liver Abscesses associated with Pylephlebitis Mimic Hepatocellular Carcinoma Chih-Hao Shen, MD 3, Jung-Chung Lin, MD, PhD 2, Hsuan-Hwai Lin, MD 1, You-Chen Chao, MD 1, and Tsai-Yuan
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationVenous Thromboembolism. Prevention
Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and
More informationVenous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community
Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer
More informationDr. Rami M. Adil Al-Hayali Assistant Professor in Medicine
Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL
More informationTHROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO
THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO DISCLAIMER I m a pediatrician I will be discussing this issue primarily from a pediatric perspective
More informationJessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks
Jessica Bryan, Natalia Evans, Karlyn Henderson, & Whitney Parks 1. What is the most common cause of death in hospitalized patients? 1. Hospital-acquired infection 2. Pulmonary embolism 3. Myocardial infarction
More informationGuidelines for Anticoagulation in Paediatric Cardiac Patients
Leeds Children s Hospital Guidelines for Anticoagulation in Paediatric Cardiac Patients SURGICAL PATIENTS Preoperative Management Blalock-Taussig (BT) Shunt / Fontan circulation / Sano Shunt and Severe
More informationClinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates
Clinical and Molecular Characteristics of Community- Acquired Methicillin-Resistant Staphylococcus Aureus Infections In Chinese Neonates Xuzhuang Shen Beijing Children's Hospital, Capital Medical University,
More informationDr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust
MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital
More informationDEEP VEIN THROMBOSIS (DVT): TREATMENT
DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada
More informationTable 2: Outcomes measured. Table 1: Intrapleural alteplase instillation therapy protocol
ORIGINAL RESEARCH ARTICLE Intrapleural F brinolytic Therapy with Alteplase in Empyema Thoracis in Children conducted in the Department of Pediatric critical care and Pulmonology unit at our institution
More informationVENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital
More informationHow long to continue anticoagulation after DVT?
How long to continue anticoagulation after DVT? Dr. Nihar Ranjan Pradhan M.S., DNB (Vascular Surgery), FVES(UK) Consultant Vascular Surgeon Apollo Hospital, Jubilee Hills, Hyderabad (Formerly Faculty in
More informationPulmonary Thromboembolism
Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU
More informationApproach to Thrombosis
Approach to Thrombosis Theera Ruchutrakool, M.D. Division of Hematology Department of Medicine Siriraj Hospital Faculty of Medicine Mahidol University Approach to Thrombosis Thrombosis: thrombus formation
More informationNew Strategies in the Management of Patients with Severe Sepsis
New Strategies in the Management of Patients with Severe Sepsis Michael Zgoda, MD, MBA President, Medical Staff Medical Director, ICU CMC-University, Charlotte, NC Factors of increases in the dx. of severe
More informationThrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI
Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri
More informationDisclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None
Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)
More informationManagement of Acute Haematogenous Osteomyelitis. SAPOS ICL 2017 Anthony Robertson
Management of Acute Haematogenous Osteomyelitis SAPOS ICL 2017 Anthony Robertson Diagnosis Diagnosis RED FLAGS: Nunn, Rollinson;; SAMJ 2007 Acute hip pain in a child Infant with loss of movement in a limb
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationENAL VEIN ROMBOSIS WHAT WAS IT? DR.JANANI SANKAR UNIT DR. KEDARI NAGARJUNA, DNB P KKCTH
ENAL VEIN ROMBOSIS WHAT WAS IT? DR.JANANI SANKAR UNIT DR. KEDARI NAGARJUNA, DNB P KKCTH RESENTING COMPLAINTS: u 9 ¾ yrs, boy u Fever, Loose stools 10 days back u Right sided Abdominal pain+ NVESTIGATIONS
More informationHandbook for Venous Thromboembolism
Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and
More informationReducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge
Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein
More informationDraft Agreed by Cardiovascular Working Party 28 September Adoption by CHMP for release for consultation 12 October 2017
1 2 3 4 5 6 7 8 9 10 12 October 2017 EMA/230866/2017 Committee for Medicinal Products for Human Use (CHMP) Concept paper on the need for a paediatric addendum of the guideline on clinical investigation
More informationThe following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.
Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse
More informationOsteomieliti STEOMIE
OsteomielitiSTEOMIE Osteomyelitis is the inflammation of bone caused by pyogenic organisms. Major sources of infection: - haematogenous spread - tracking from adjacent foci of infection - direct inoculation
More informationESIM 2014 Clinical Case Presentation Israel. Ben-Sasson Maayan Bnei-Zion medical center Haifa
ESIM 2014 Clinical Case Presentation Israel Ben-Sasson Maayan Bnei-Zion medical center Haifa Presentation A 24 YO male,a ping-pong player, presented to the ER with acute onset of right upper extremity
More informationPULMONARY EMBOLISM -CASE REPORT-
University Goce Delcev, Faculty of Medical sciences, Stip University Clinic of Cardiology, Skopje R. Of Macedonia PULMONARY EMBOLISM -CASE REPORT- Gordana Kamceva MD mr.sci Acknowledgment Marija Vavlukis
More informationHEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) OBJECTIVE: To assist clinicians with the investigation and management of suspected and documented heparin-induced thrombocytopenia (HIT). BACKGROUND: HIT is a transient,
More informationUniversity Journal of Medicine and Medical Specialities
University Journal of Medicine and Medical Specialities Volume 1 Issue 1 2015 An unusual case of SADDLE Pulmonary Thrombo Embolism Boopathirajan P Jayanthi R Stanley Medical College Abstract: Pulmonary
More informationIs there a correlation between injecting heroin into the groin and abscesses, leg. ulcers, deep vein thromboses and pulmonary emboli?
Is there a correlation between injecting heroin into the groin and abscesses, leg ulcers, deep vein thromboses and pulmonary emboli? School of Medicine, University of Manchester 18 th June 2010 Supervisor:
More informationPROGNOSIS AND SURVIVAL
CANCER ASSOCIATED THROMBOSIS PROGNOSIS AND SURVIVAL Since French internist Armand Trousseau reported the occurrence of mysterious thrombotic disorders in cancer patients in the mid-19th century, the link
More informationWhat are blood clots?
What are blood clots? Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service GP Partner Westcliffe Medical Group Created 5/31/18 Dr. Matthew
More informationRisk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease
Risk Factor Evaluation for Thrombosis and Bleeding in Pediatric Patients with Heart Disease Kristen Nelson, MD Johns Hopkins University Director, Pediatric Cardiac Critical Care Why Does it Matter? Pediatric
More informationPathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University
Pathology of pulmonary vascular disease Dr.Ashraf Abdelfatah Deyab Assistant Professor of Pathology Faculty of Medicine Almajma ah University Pulmonary vascular disease Type of pulmonary circulation: Types
More informationVenous Thromboembolism Prophylaxis
Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January
More informationVenous Thromboembolism National Hospital Inpatient Quality Measures
Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation
More informationA 50-year-old woman with syncope
Hira Shahzad 1, Ali Bin Sarwar Zubairi 2 1 Medical College, Aga Khan University Hospital, Karachi 2 Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan Ali Bin Sarwar Zubairi Associate
More informationThe Challenge of Managing Staphylococcus aureus Bacteremia
The Challenge of Managing Staphylococcus aureus Bacteremia M A R G A R E T G R A Y B S P F C S H P C L I N I C A L P R A C T I C E M A N A G E R N O R T H / I D P H A R M A C I S T A L B E R T A H E A
More informationPathophysiology. Tutorial 3 Hemodynamic Disorders
Pathophysiology Tutorial 3 Hemodynamic Disorders ILOs Recall different causes of thrombosis. Explain different types of embolism and their predisposing factors. Differentiate between hemorrhage types.
More information10/24/2013. Heparin-Induced Thrombocytopenia (HIT) Anticoagulation Management in ECMO Therapy:
Anticoagulation Management in ECMO Therapy: Heparin-Induced (HIT) Michael H. Creer, MD Professor of Pathology Director, Clinical Laboratories, Medical Co- Director, Hematopathology and Chief, Division
More information1. SCOPE of GUIDELINE:
Page 1 of 35 CLINICAL PRACTICE GUIDELINE: Venous Thromboembolism (VTE) Prevention Guideline: Thromboprophylaxis AUTHORIZATION: VP, Medicine Date Approved: May 17, 2012 Date Revised: Vancouver Coastal Health
More informationInfections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)
3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition
More informationGram Positive Coccus Staphylococci Dr. Hala Al Daghistani
Medical bacteriology Gram Positive Coccus Staphylococci Dr. Hala Al Daghistani The Staphylococci are gram-positive spherical cells, nonmotile, usually arranged in grapelike irregular clusters. Some are
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationPrevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales
Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital
More informationMichael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center
CA-MRSA Pneumonia Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center Professor of Clinical Medicine Weill Cornell
More information4. Which survey program does your facility use to get your program designated by the state?
TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and
More informationOsteomyelitis in infancy and childhood: A clinical and diagnostic overview M. Mearadji
Osteomyelitis in infancy and childhood: A clinical and diagnostic overview M. Mearadji International Foundation for Pediatric Imaging Aid Introduction Osteomyelitis is a relative common disease in infancy
More informationEAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary
EAST MULTICENTER STUDY DATA DICTIONARY Temporary Intravascular Shunt Study Data Dictionary Data Entry Points and appropriate definitions / clarifications: Entry space Definition / Instructions 1. Specific
More informationThrombosis. By Dr. Sara Mohamed Abuelgasim
Thrombosis By Dr. Sara Mohamed Abuelgasim 1 Thrombosis Unchecked, blood coagulation would lead to dangerous occlusion of blood vessels if the protective mechanisms of coagulation factor inhibitors, blood
More informationA 48-Year Old Woman with Recurrent Venous Thromboembolism and Pulmonary Artery Aneurysm
A 48-Year Old Woman with Recurrent Venous Thromboembolism and Pulmonary Artery Aneurysm Group 10: Arjun Prasanna, Keaton Mcclure, Shruti Srikumar, Nisha Karwal Patient History: 15 months prior 48 year
More informationOnline Supplementary Data. Country Number of centers Number of patients randomized
A Randomized, Double-Blind, -Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular
More information4/30/2018 CLOT+ In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce t
In patients with an acute proximal deep vein thrombosis, pharmacomechanical catheter-directed thrombolysis does not reduce the rate of post-thrombotic syndrome Question In patients who have symptomatic
More information(telavancin) Healthcare Professional s Guide. Version 2, 4 November 2014
VIBATIV (telavancin) Healthcare Professional s Guide Version 2, 4 November 2014 1 Table of Contents Introduction... 3 About Vibativ / Therapeutic indications... 3 Antimicrobial spectrum of activity for
More informationDVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)
DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness
More informationUpdates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan
Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan Objectives Describe the prevalence of PE and DVT as it relates
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 2.417, ISSN: , Volume 3, Issue 11, December 2015
MANAGEMENT OF PATHOLOGICAL FRACTURE SHAFT HUMERUS SECONDARY TO BACTERIAL OSTEOMYELITIS: A CASE REPORT DR. NARENDRA SINGH KUSHWAHA* DR.SHAH WALIULLAH** DR.VINEET KUMAR*** DR.VINEET SHARMA**** *Asst. Professor,
More informationPatients with suspected DVT of the lower limb how to exam the patient
Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology
More informationSlide 1. Slide 2. Slide 3. Outline of This Presentation
Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous
More informationSupplementary Online Content
Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone
More informationA Brief Guide Treatment and Prevention
A Brief Guide Treatment and Prevention Deep Vein Thrombosis and Pulmonary Embolism 08/18 Dear reader, This brochure provides you with information about deep vein thrombosis and pulmonary embolism. This
More informationDr Shikha Chattree Haematology Consultant Sunderland Royal infirmary
Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Increasing use of Novel Oral Anticoagulants (NOACs) in the management of prophylaxis and management of venous thromboembolism and in
More informationCHAPTER 2 VENOUS THROMBOEMBOLISM
CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology
More informationStaphylococci. What s to be Covered. Clinical Scenario #1
Staphylococci Micrococcus, which, when limited in its extent and activity, causes acute suppurative inflammation (phlegmon), produces, when more extensive and intense in its action on the human system,
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationRisk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD
Risk factors for DVT Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationVenous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD
Venous thrombosis & pulmonary embolism Ahmed Mahmoud, MD Risk factors for DVT Surgery ; post op especially for long cases, pelvic operations (THR), Trauma ; long bone fractures, pelvic fractures (posterior
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationWhat s to be Covered. Microbiology of staphylococci Epidemiology of S. aureus infections Pathogenesis of S. aureus infections
Staphylococci Micrococcus, which, when limited in its extent and activity, causes acute suppurative inflammation (phlegmon), produces, when more extensive and intense in its action on the human system,
More informationDVT and Pulmonary Embolus. Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre
DVT and Pulmonary Embolus Dr Piers Blombery BSc(Biomed), MBBS (Hons), FRACP, FRCPA Consultant Haematologist Peter MacCallum Cancer Centre Overview Structure of deep and superficial venous system of upper
More informationNICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1
The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS
More informationTRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006
TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.
More informationOctober 2017 Pulmonary Embolism
October 2017 Pulmonary Embolism Prof. Ahmed BaHammam, FRCP, FCCP Professor of Medicine College of Medicine King Saud University 1 Objectives Epidemiology Pathophysiology Diagnosis Massive PE Treatment
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue
More informationMisunderstandings of Venous thromboembolism prophylaxis
Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario
More informationCANCER ASSOCIATED THROMBOSIS. Pankaj Handa Department of General Medicine Tan Tock Seng Hospital
CANCER ASSOCIATED THROMBOSIS Pankaj Handa Department of General Medicine Tan Tock Seng Hospital My Talk Today 1.Introduction 2. Are All Cancer Patients at Risk of VTE? 3. Should All VTE Patients Be Screened
More informationSteroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye
Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye Steroids in ARDS: conclusion Give low-dose steroids if indicated for another problem
More informationDave Duddleston, MD VP and Medical Director Southern Farm Bureau Life
Dave Duddleston, MD VP and Medical Director Southern Farm Bureau Life Sources of Risk for Venous Diseases Pulmonary embolism (thrombus) Bleeding from anticoagulation Mortality from underlying disease Chronic
More informationObjectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?
Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP
More informationconvey the clinical quality measure's title, number, owner/developer and contact
CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical
More informationMATERIALS AND METHODS
RETROSPECTIVE STUDY OF OPTIMISING THE USE OF COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAPHY (CTPA) FOR THE DIAGNOSIS OF PULMONARY EMBOLISM IN PLACES WITH LIMITED RESOURCES P. V. Kalyan Kumar 1, Ramakrishna
More informationBEDSIDE ULTRASOUND BEDSIDE ULTRASOUND. Deep Vein Thrombosis. Probe used
BEDSIDE ULTRASOUND Part 2 Diagnosis of deep vein thrombosis Kishore Kumar Pichamuthu, Professor, Department of Critical Care, CMC, Vellore Summary: Deep vein thrombosis (DVT) is a problem encountered in
More informationThe Association of Septic Thrombophlebitis with Septic Pulmonary Embolism in Adults
14 The Open Respiratory Medicine Journal, 2012, 6, 14-19 The Association of Septic Thrombophlebitis with Septic Pulmonary Embolism in Adults Jorge A. Brenes *,1, Umesh Goswami 1 and David N. Williams 2
More information2.3 Invasive Group A Streptococcal Disease
2.3 Invasive Group A Streptococcal Disease Summary Total number of cases, 2015 = 107 Crude incidence rate, 2015 = 2.3 per 100,000 population Notifications In 2015, 107 cases of invasive group A streptococcal
More informationGUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS
GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS This guideline covers the management of patients being treated with Vitamin K antagonists (VKA): Warfarin Acenocoumarol
More informationData Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:
Data Collection Tool Standard Study Questions: Admission Date: Admission Time: Age: Gender: Specifics of Injury: Time of Injury: Mechanism of Injury Blunt vs Penetrating? Injury Severity Score? Injuries:
More informationNOTE: Deep Vein Thrombosis (DVT) Risk Factors
Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the
More informationGuidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban
Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting
More information